Literature DB >> 19484497

History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany).

Gabriele Berg-Beckhoff1, Joachim Schüz, Maria Blettner, Eva Münster, Klaus Schlaefer, Jürgen Wahrendorf, Brigitte Schlehofer.   

Abstract

The aim of the present analysis was to examine the association of a medical history of asthma, hay fever, eczema, or epilepsy with the risk of glioma and meningioma. Data of a German population-based case-control study included 381 meningioma cases, 366 glioma cases, and 1,494 controls. Participants' histories of asthma, hay fever, eczema, and epilepsy and the respective ages at onset were asked during a personal interview. A small inverse association between allergic condition and both glioma (odds ratio: 0.92; 95% CI: 0.70-1.22) and meningioma (odd ratio: 0.87; 95% CI: 0.66-1.14) was found. For glioma, this inverse association was more pronounced in persons reporting to have asthma compared to other allergic conditions. The positive association between epilepsy and particularly glioma suggests that epilepsy is an early symptom of the disease. As the association was seen also for epilepsies occurring more than a decade before the diagnosis of glioma, this might indicate either an aetiological role of epilepsy, or a relatively long preclinical phase. In conclusion our study confirms previous findings of case control studies but not those from cohort studies. However, possible selection bias in case control studies might not explain the different results in its entirety.

Entities:  

Mesh:

Year:  2009        PMID: 19484497     DOI: 10.1007/s10654-009-9355-6

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  31 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  History of allergies and risk of glioma in adults.

Authors:  Minouk J Schoemaker; Anthony J Swerdlow; Sarah J Hepworth; Patricia A McKinney; Martie van Tongeren; Kenneth R Muir
Journal:  Int J Cancer       Date:  2006-11-01       Impact factor: 7.396

3.  Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk.

Authors:  Judith Schwartzbaum; Fredrik Jonsson; Anders Ahlbom; Susan Preston-Martin; Beatrice Malmer; Stefan Lönn; Karin Söderberg; Maria Feychting
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

4.  History of allergic disease and risk of meningioma.

Authors:  M J Schoemaker; A J Swerdlow; S J Hepworth; M van Tongeren; K R Muir; P A McKinney
Journal:  Am J Epidemiol       Date:  2006-12-20       Impact factor: 4.897

Review 5.  Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management.

Authors:  Melanie S M van Breemen; Erik B Wilms; Charles J Vecht
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

6.  History of allergies among adults with glioma and controls.

Authors:  Joseph L Wiemels; John K Wiencke; Jennette D Sison; Rei Miike; Alex McMillan; Margaret Wrensch
Journal:  Int J Cancer       Date:  2002-04-01       Impact factor: 7.396

7.  Cellular phones, cordless phones, and the risks of glioma and meningioma (Interphone Study Group, Germany).

Authors:  Joachim Schüz; Eva Böhler; Gabriele Berg; Brigitte Schlehofer; Iris Hettinger; Klaus Schlaefer; Jürgen Wahrendorf; Katharina Kunna-Grass; Maria Blettner
Journal:  Am J Epidemiol       Date:  2006-01-27       Impact factor: 4.897

8.  Cancer mortality among US men and women with asthma and hay fever.

Authors:  Michelle C Turner; Yue Chen; Daniel Krewski; Parviz Ghadirian; Michael J Thun; Eugenia E Calle
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

9.  Prevalence and prognostic significance of epilepsy in patients with gliomas.

Authors:  K Lote; A E Stenwig; K Skullerud; H Hirschberg
Journal:  Eur J Cancer       Date:  1998-01       Impact factor: 9.162

10.  Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma.

Authors:  A V Brenner; M A Butler; S S Wang; A M Ruder; N Rothman; P A Schulte; S J Chanock; H A Fine; M S Linet; P D Inskip
Journal:  Carcinogenesis       Date:  2007-10-04       Impact factor: 4.944

View more
  26 in total

1.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design.

Authors:  Xin Gao; Albert Hofman; Yu Hu; Huandong Lin; Chouwen Zhu; Johannes Jeekel; Xuejuan Jin; Jiyao Wang; Jian Gao; Yiqing Yin; Naiqing Zhao
Journal:  Eur J Epidemiol       Date:  2010-12-01       Impact factor: 8.082

2.  Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects.

Authors:  Hongyu Zhao; Weisong Cai; Shitao Su; Debao Zhi; Jie Lu; Shuo Liu
Journal:  Tumour Biol       Date:  2013-12-18

3.  Association of the interleukin-4Rα rs1801275 and rs1805015 polymorphisms with glioma risk.

Authors:  Jun Guo; Lei Shi; Min Li; Jin Xu; Shushan Yan; Chuang Zhang; Guan Sun
Journal:  Tumour Biol       Date:  2013-08-27

4.  Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.

Authors:  E Susan Amirian; Renke Zhou; Margaret R Wrensch; Sara H Olson; Michael E Scheurer; Dora Il'yasova; Daniel Lachance; Georgina N Armstrong; Lucie S McCoy; Ching C Lau; Elizabeth B Claus; Jill S Barnholtz-Sloan; Joellen Schildkraut; Francis Ali-Osman; Siegal Sadetzki; Christoffer Johansen; Richard S Houlston; Robert B Jenkins; Jonine L Bernstein; Ryan T Merrell; Faith G Davis; Rose Lai; Sanjay Shete; Christopher I Amos; Beatrice S Melin; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

Review 5.  The epidemiology of glioma in adults: a "state of the science" review.

Authors:  Quinn T Ostrom; Luc Bauchet; Faith G Davis; Isabelle Deltour; James L Fisher; Chelsea Eastman Langer; Melike Pekmezci; Judith A Schwartzbaum; Michelle C Turner; Kyle M Walsh; Margaret R Wrensch; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

6.  Allergic conditions and risk of glioma and meningioma in the CERENAT case-control study.

Authors:  Camille Pouchieu; Chantal Raherison; Clément Piel; Lucile Migault; Camille Carles; Pascale Fabbro-Perray; Hugues Loiseau; Jean-Sébastien Guillamo; Pierre Lebailly; Isabelle Baldi
Journal:  J Neurooncol       Date:  2018-03-02       Impact factor: 4.130

7.  Family and personal medical history and risk of meningioma.

Authors:  Elizabeth B Claus; Lisa Calvocoressi; Melissa L Bondy; Joellen M Schildkraut; Joseph L Wiemels; Margaret Wrensch
Journal:  J Neurosurg       Date:  2011-07-22       Impact factor: 5.115

8.  Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States.

Authors:  Monica D'Arcy; Donna R Rivera; Andrew Grothen; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

Review 9.  Season of birth and risk for adult onset glioma.

Authors:  Jimmy T Efird
Journal:  Int J Environ Res Public Health       Date:  2010-04-28       Impact factor: 3.390

Review 10.  Epidemiology and etiology of meningioma.

Authors:  Joseph Wiemels; Margaret Wrensch; Elizabeth B Claus
Journal:  J Neurooncol       Date:  2010-09-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.